BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19139816)

  • 21. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
    Chen TC; da Fonseca CO; Schönthal AH
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
    Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
    J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    Blystad I; Warntjes JBM; Smedby Ö; Lundberg P; Larsson EM; Tisell A
    PLoS One; 2017; 12(5):e0177135. PubMed ID: 28542553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between the degree of contrast enhancement and the volume of peritumoral edema in meningiomas and malignant gliomas.
    Holodny AI; Nusbaum AO; Festa S; Pronin IN; Lee HJ; Kalnin AJ
    Neuroradiology; 1999 Nov; 41(11):820-5. PubMed ID: 10602854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
    Cloughesy TF; Wen PY; Robins HI; Chang SM; Groves MD; Fink KL; Junck L; Schiff D; Abrey L; Gilbert MR; Lieberman F; Kuhn J; DeAngelis LM; Mehta M; Raizer JJ; Yung WK; Aldape K; Wright J; Lamborn KR; Prados MD
    J Clin Oncol; 2006 Aug; 24(22):3651-6. PubMed ID: 16877733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.
    Rudnick JD; Sarmiento JM; Uy B; Nuno M; Wheeler CJ; Mazer MJ; Wang H; Hu JL; Chu RM; Phuphanich S; Black KL; Yu JS
    J Clin Neurosci; 2020 Apr; 74():187-193. PubMed ID: 32169363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological findings in the peritumoral edema area of human glioma.
    Wang X; Liu X; Chen Y; Lin G; Mei W; Chen J; Liu Y; Lin Z; Zhang S
    Histol Histopathol; 2015 Sep; 30(9):1101-9. PubMed ID: 25780990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
    Phuphanich S; Carson KA; Grossman SA; Lesser G; Olson J; Mikkelsen T; Desideri S; Fisher JD;
    Neuro Oncol; 2008 Aug; 10(4):617-23. PubMed ID: 18477765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
    Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
    J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
    Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
    J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of diffusion kurtosis imaging to the study of edema in solid and peritumoral areas of glioma.
    Qiu J; Deng K; Wang P; Chen C; Luo Y; Yuan S; Wen J
    Magn Reson Imaging; 2022 Feb; 86():10-16. PubMed ID: 34793876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of bevacizumab therapy in recurrent malignant gliomas in relation to the prior recurrence pattern or tumor location.
    Matsuda M; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Matsumura A
    J Clin Neurosci; 2017 Jun; 40():115-119. PubMed ID: 28246006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
    Wang XB; Tian XY; Li Y; Li B; Li Z
    J Neurooncol; 2012 Jan; 106(1):43-51. PubMed ID: 21725855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF Inhibition in
    Kaley T; Touat M; Subbiah V; Hollebecque A; Rodon J; Lockhart AC; Keedy V; Bielle F; Hofheinz RD; Joly F; Blay JY; Chau I; Puzanov I; Raje NS; Wolf J; DeAngelis LM; Makrutzki M; Riehl T; Pitcher B; Baselga J; Hyman DM
    J Clin Oncol; 2018 Dec; 36(35):3477-3484. PubMed ID: 30351999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
    Burger MC; Mildenberger IC; Wagner M; Mittelbronn M; Steinbach JP; Bähr O
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy.
    Silva MM; Da Fonseca CO; Moura-Neto R; Carvalho JF; Quirico-Santos T; Carvalho MG
    Genet Mol Res; 2013 May; 12(2):1621-30. PubMed ID: 23765968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.